These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23276629)

  • 1. Management of symptoms of Restless Legs Syndrome with use of a traction straight leg raise: a preliminary case series.
    Dinkins EM; Stevens-Lapsley J
    Man Ther; 2013 Aug; 18(4):299-302. PubMed ID: 23276629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS.
    Rajaram SS; Shanahan J; Ash C; Walters AS; Weisfogel G
    Sleep Med; 2005 Mar; 6(2):101-6. PubMed ID: 15716213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
    Allen RP; Ritchie SY
    Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restless legs syndrome and near-infrared light: An alternative treatment option.
    Mitchell UH; Myrer JW; Johnson AW; Hilton SC
    Physiother Theory Pract; 2011 Jul; 27(5):345-51. PubMed ID: 20977377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restless legs syndrome: clinical experience with long-term treatment.
    Clavadetscher SC; Gugger M; Bassetti CL
    Sleep Med; 2004 Sep; 5(5):495-500. PubMed ID: 15341896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency, severity and risk factors for restless legs syndrome in healthcare personnel.
    Civi S; Kutlu R; Tokgoz S
    Neurosciences (Riyadh); 2012 Jul; 17(3):230-5. PubMed ID: 22772928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
    Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
    Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Evidence on Diagnostic Criteria, Relevant Outcome Measures, and Efficacy of Nonpharmacologic Therapy in the Management of Restless Legs Syndrome (RLS): A Scoping Review.
    Guay A; Houle M; O'Shaughnessy J; Descarreaux M
    J Manipulative Physiol Ther; 2020; 43(9):930-941. PubMed ID: 32900545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise and restless legs syndrome: a randomized controlled trial.
    Aukerman MM; Aukerman D; Bayard M; Tudiver F; Thorp L; Bailey B
    J Am Board Fam Med; 2006; 19(5):487-93. PubMed ID: 16951298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restless Legs Syndrome: a common disorder, but rarely diagnosed and barely treated--an Indian experience.
    Gupta R; Lahan V; Goel D
    Sleep Med; 2012 Aug; 13(7):838-41. PubMed ID: 22704403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation.
    Winkelmann J; Stautner A; Samtleben W; Trenkwalder C
    Mov Disord; 2002 Sep; 17(5):1072-6. PubMed ID: 12360562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline--an open clinical trial.
    Stiasny K; Röbbecke J; Schüler P; Oertel WH
    Sleep; 2000 May; 23(3):349-54. PubMed ID: 10811379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome.
    Benes H
    Sleep Med; 2006 Jan; 7(1):31-5. PubMed ID: 16194624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion and restless legs syndrome: a randomized controlled trial.
    Bayard M; Bailey B; Acharya D; Ambreen F; Duggal S; Kaur T; Rahman ZU; Roller K; Tudiver F
    J Am Board Fam Med; 2011; 24(4):422-8. PubMed ID: 21737767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs syndrome in end-stage renal disease.
    Gigli GL; Adorati M; Dolso P; Piani A; Valente M; Brotini S; Budai R
    Sleep Med; 2004 May; 5(3):309-15. PubMed ID: 15165541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless legs syndrome in patients with sequelae of poliomyelitis.
    Kumru H; Portell E; Barrio M; Santamaria J
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1056-8. PubMed ID: 25042342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall self-perceived health in Restless legs treated with intrathecal morphine.
    Lindvall P; Hariz GM; Blomstedt P
    Acta Neurol Scand; 2013 Apr; 127(4):268-73. PubMed ID: 22881705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
    Giorgi L; Asgharian A; Hunter B
    Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.